96695 ⎘
Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links; Dipeptides with the first amino acid being acidic Asp- or Asn-amino acid
Sub-classes:PREPARATION METHOD, INTERMEDIATES, AND USE OF CYCLIC PEPTIDE TOXIN ALPHA-AMANITIN AND/OR AMANINAMIDE
#2CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#3PSMA Imaging Agents
#4PSMA Imaging Agents
#5AMIDE DERIVATIVES OF N-UREA SUBSTITUTED AMINO ACIDS AS FORMYL PEPTIDERECEPTOR LIKE-1 (FPRL-1) RECEPTOR MODULATORS
#6METHOD FOR PRODUCING GLYCOPEPTIDE
#7FLUORESCENT PROBE FOR USE IN DETECTION OF PANCREATIC CANCER
#8LINKER COMPOUNDS COMPRISING AMIDE BONDS
#9PSMA BINDER AND USE THEREOF
#10CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#11AMIDE DERIVATIVES OF N-UREA SUBSTITUTED AMINO ACIDS AS FORMYL PEPTIDE RECEPTOR LIKE-1 (FPRL-1) RECEPTOR MODULATORS
#12COMBINING BETA-DIPEPTIDES AND AMINO ACIDS FOR OPTIMAL NUTRITIONAL SUPPLEMENTATION
#13BIOLOGICALLY ACTIVE C-TERMINAL ARGININE-CONTAINING PEPTIDES
#14CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#15CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#16PSMA Imaging Agents
#17PSMA imaging agents
#18PSMA imaging agents
#19Mild and efficient preparation method for α-acyloxyenamide compounds and use thereof in synthesis of amide and polypeptide
#20N-acyldipeptide derivatives and their uses
#21Tripeptide epoxy ketone protease inhibitors
#22Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#23CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#24Mild and efficient preparation method for α-acyloxyenamide compounds and use thereof in synthesis of amide and polypeptide
#25Carbonic anhydrase IX inhibitor conjugates and uses thereof
#26Skin treatment devices and methods with pre-stressed configurations
#27Combination of N-acyldipeptide derivatives and retinol, and methods of use thereof
#28CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#29CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#30PSMA imaging agents
#31Conjugates for treating diseases caused by PSMA expressing cells
#32CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#33CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#34CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#35CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#36Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#37Selective cysteine protease inhibitors and uses thereof
#38Lipid assemblies and uses thereof and some pH and electrostatic modulating lipids to be used in said assemblies
#39BIOLOGICALLY ACTIVE C-TERMINAL ARGININE-CONTAINING PEPTIDES
#40Substrates and inhibitors of prolyl oligopeptidase and methods of use thereof
#41Dipeptides as inhibitors of human immunoproteasomes
#42Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#43N-acyldipeptide derivatives and their uses
#44Biologically active C-terminal arginine-containing peptides
#45Tripeptide epoxy ketone protease inhibitors
#46Conjugates for treating diseases caused by PSMA expressing cells
#47Methods of producing cancer targeting compounds
#48Methods of producing cancer treating compounds
#49PSMA imaging agents
#50Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#51Skin treatment devices and methods with pre-stressed configurations
#52Gellant
#53Methods of producing cancer compounds
#54Gadd45beta targeting agents
#55Amphiphilic linear peptide/peptoid and hydrogel comprising the same
#56Compounds for enzyme inhibition
#57Lead compound for otoprotection: targeting HGF signaling with dihexa
#58Conjugates for treating diseases caused by PSMA expressing cells
#59Pro-substrates for live cell applications
#60DNA encoding dipeptide-synthesizing enzyme (variants), bacterium belonging to the genus , and methods for producing dipeptides using thereof
#61ANGIOTENSIN-CONVERTING-ENZYME INHIBITING DIPEPTIDE
#62Peptides and use thereof
#63Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#64Substrates and inhibitors of prolyl oligopeptidase and methods of use
#65Dipeptide mimetics of NGF and BDNF neurotrophins
#66Lipoyl compounds and methods for treating ischemic injury
#67GLP-1 receptor modulators
#68Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#69Selective cysteine protease inhibitors and uses thereof
#70Lipoyl compounds and their use for treating ischemic injury
#71Skin treatment devices and methods with pre-stressed configurations
#72Compounds for enzyme inhibition
#73Compounds for enzyme inhibition
#74Compounds for enzyme inhibition
#75C-Met receptor regulation by angiotensin IV (AT4) receptor ligands
#76Amphiphilic linear peptide/peptoid and hydrogel comprising the same
#77Method for producing α-L-aspartyl-L-phenylalanine-β-ester and method for producing α-L-aspartyl-L-phenylalanine-α-methyl ester
#78Method for producing α-L-aspartyl-L-phenylalanine-β-ester and method for producing α-L-aspartyl-L-phenylalanine-α-methyl ester
#79Gadd45beta targeting agents
#80Process for preparing peptide products for promoting cholecystokinin secretion and use of the peptide products
#81Trypsin-like serine protease inhibitors, their preparation and use as selective inhibitors of the clotting factors IIa and Xa
#82Compounds for enzyme inhibition
#83Treatment devices and methods with extending elements
#84Skin treatment devices and methods with pre-stressed configurations
#85Method for producing α-L-aspartyl-L-phenylalanine-β-ester and method for producing α-L-aspartyl-L-phenylalanine-α-methyl ester
#86DIPEPTIDE MIMETICS OF NGF AND BDNF NEUROTROPHINS
#87Dipeptoid prodrugs and the use thereof
#88Oligomeric biosurfactants in dermatocosmetic compositions
#89T-cell antigen peptide from allergen for stimulation of IL-10 production
#90ENZYME SUBSTRATE FOR LABELING OF PROTEIN
#91ANTI-INFLAMMATORY PEPTIDE
#92Biologically active C-terminal arginine-containing peptides
#93Angiotensin converting enzyme inhibitory peptide
#94Method for producing α-L-aspartyl-L-phenylalanine-β-ester and method for producing α-L-aspartyl-L-phenylalanine-α-methyl ester
#95Synthesis of N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester using 3,3-dimethylbutyraldehyde precursors
#96Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof
#97Compounds for enzyme inhibition
#98Compounds for enzyme inhibition
#99O-SUBSTITUTED HYDROXYARYL DERIVATIVES
#100Targeted delivery to legumain-expressing cells
#101PROPHYLACTIC OR THERAPEUTIC AGENT FOR DIARRHEA
#102PHARMACEUTICALLY ACTIVE COMPOUNDS
#103AMINO ACID DERIVED PRODRUGS OF PROPOFOL, COMPOSITIONS AND USES THEREOF
#104Process for preparing peptide products for promoting cholecystokinin secretion and use of the peptide products
#105Method for producing α-L-aspartyl-L-phenylalanine-β-ester and method for producing α-L-aspartyl-L-phenylalanine-α-methyl ester
#106Methods for the treatment or prevention of scars and/or keloids
#107Biologically active C-terminal arginine-containing peptides
#108Melanin eliminator preparation
#109Amide forming chemical ligation
#110Peptides and chemical compound for inhibition of SHP2 function
#111Non-Natural Amino Acid Derivatives
#112POLYBASIC BACTERIAL EFFLUX PUMP INHIBITORS AND THERAPEUTIC USES THEREOF
#113C-Met receptor regulation by angiotensin IV (AT) receptor ligands
#114Methods for the synthesis of cyclic peptides
#115Fluorous capping reagents and methods for peptide purification
#116Hiv Prodrugs Cleavable by Cd26
#117Macrocyclic Sh2 Domain Binding Inhibitors
#118SYNTHESIS OF N-[N-(3,3-DIMETHYLBUTYL)-L-ALPHA-ASPARTYL]-L-PHENYLALANINE 1-METHYL ESTER USING 3,3-DIMETHYLBUTYRALDEHYDE PRECURSORS
#119Peptides and chemical compound for inhibition of SHP2 function
#120Compounds for enzyme inhibition
#121Antithrombotic compound
#122Prodrugs cleavable by CD26
#123Amino acid conjugates providing for sustained systemic concentrations of GABA analogues
#124N- or C- terminally modified small peptides
#125Process for the preparation of 3,3-dimethylbutanal
#126Amide forming chemical ligation
#127Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of PHEX
#128Peptide gap junction modulators
#129Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of phex
#130Targeted delivery to legumain-expressing cells
#131Melanin extinguisher
#132Novel thrombin inhibitors, the preparation and use thereof
#133Amino acid derived prodrugs of propofol, compositions and uses thereof
#134O-substituted hydroxyaryl derivatives
#135Glycopeptide and peptide having a taste imparting function, and method of imparting the taste to foods
#136Process for producing cinnamaldehyde derivatives, use thereof and the like
#137Process for production of aspartyl dipeptide ester derivative, novel production intermediate therefor, and process for production thereof
#138Method for producing α-L-aspartyl-L-phenylalanine-β-ester and method for producing α-L-aspartyl-L-phenylalanine-α-methyl ester
#139Process for the preparation of peptides
#140Suppression of immune response via inhibition of cathepsin S
#141Suppression of immune response via inhibition of cathepsin S
#142Isotopically coded affinity markers 3
#143Novel intermediate for sweetener with high sweetness and process for producing the same
#144Synthesis of N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester using oxazolidinone derivatives